31 mei 2026: Bron Foodlog en BRILL

Foodlog heeft een mooi en uitgebreid artikel met de titel: Gezonde voeding is een kwestie van proberen. Zij haken in op een studie van Dennis Zijlstra en collega's over de rol die artsen en dietisten hebben in de dagelijkse praktijk als het gaast om de vraag wat is nou gezonde voeding. 

Een citaat uit het artikel: 

Leren en proberen

Dennis Zeilstra en enkele collega-onderzoekers publiceerden in januari een artikel dat begint bij die lastige vraag. Niet welke medische behandeling of dieet het beste is, maar hoe gebruik je bestaande 'algemene' kennis om tot een concreet en passend advies te komen in specifieke gevallen? 

Hun voorstel is nuchter: verzamel de algemeenheden van werkingen die we kennen uit onderzoek, kijk goed naar de individuele situatie van de patiënt en pas ze toe op zijn of haar situatie, kijk wat er gebeurt en leer daarvan. Zo schuift de vraag ongemerkt op van 'wat is waar?' naar 'wat werkt?

Het abstract vertaald in het Nederlands (het volledige studierapport is gratis in gte zien of te downloaden) :

Zorgverleners streven ernaar de beste medische zorg te bieden aan elke individuele patiënt. De vraag wat 'de beste' zorg precies inhoudt, kent echter geen eenduidig ​​antwoord. Evidence-based medicine (EBM) en gepersonaliseerde geneeskunde (PM) zijn twee paradigma's die zijn ontstaan ​​als middel om de selectie van interventies te verbeteren. Beide paradigma's hebben hun eigen sterke en zwakke punten die van invloed zijn op hun toepassing in klinische besluitvorming. In dit overzicht bespreken we de sterke en zwakke punten vanuit het perspectief van de patiënt en de zorgverlener: hoe de beste interventie voor een specifieke patiënt te vinden. We bespreken methodologische en praktische aspecten en zoomen uit van het wetenschappelijke niveau naar het epistemologische niveau om EBM en PM te integreren. Zowel EBM als PM zijn gebaseerd op een realistisch wereldbeeld en door een pragmatisch wereldbeeld te hanteren, kunnen de sterke punten van beide paradigma's worden gecombineerd. We passen deze pragmatische aanpak, genaamd evidence-based gepersonaliseerde geneeskunde (EBPM), toe op interventies gericht op het microbioom. De voorbeeldimplementatie van EBPM bestaat uit vier stappen. Ten eerste stelt het zorgverleners in staat om informatie (klinische diagnose, klachten, patiëntbehoeften, laboratoriumwaarden) over een individuele patiënt te verstrekken. Ten tweede gebruikt het een GRADE-gebaseerd systeem om het bewijs voor specifieke interventiecomponenten te beoordelen. Vervolgens combineert het de patiëntprofielgegevens en -voorkeuren met het beoordeelde bewijs om tot een suggestie voor een gepersonaliseerde interventie te komen. Ten slotte maakt deze methode het mogelijk om gegevens over behandeleffecten te verzamelen, feedback aan het systeem te geven en de suggesties voor toekomstige patiënten verder te verbeteren. (zie abstract verderop in dit artikel)


Ik plaats hier een link naar het artikel op foodlog en daaronder het abstract  van de studie van Dennis Zijlstra en collega's.

Gezonde voeding is een kwestie van proberen

Elske Gravesteijn Redacteur, Foodlog

We weten veel over gezonde voeding en tegelijk lang niet genoeg om eenduidig te zeggen wat werkt. Onderzoekers spreken elkaar tegen, theorieën botsen en zekerheden verschuiven. De voedingswetenschap zit vast in een impasse. Begin dit jaar verscheen een artikel dat een andere route voorstelt: zoek niet naar die ene waarheid voor iedereen, maar bepaal wat werkt één persoon.

De voedingswetenschap worstelt al jaren met de vraag wat dat schijnbaar duidelijke begrip 'gezond' precies betekent en hoe je moet eten. De zoektocht naar de sleutel tot het bestrijden van obesitas via voedingskeuzes kent tot op heden een open einde. Het debat over vetten, koolhydraten en eiwitten is onopgelost, maar is inmiddels wel wat minder zwart-wit geworden. Er is meer aandacht voor de kwaliteit van voeding. Volwaardige voedingsmiddelen zoals groenten, fruit, noten en zaden bieden voordelen, ongeacht de verhouding tussen koolhydraten, vetten en eiwitten. Gezond eten draait niet zozeer om één macronutriënt maar om het ontdekken van de voeding die bij je past.>>>>>>>lees verder   

Corresponding author; e-mail: dennis@microbiome-center.nl

Acknowledgements

The authors would like to thank and acknowledge all members of the MyOwnResearch project for the contribution to the ideas that are further developed in this article. The MyOwnResearch project (in full: MyOwnResearch: Homogeneous subgroup identification in fatigue management across chronic autoimmune syndromes through Single Subject Study design) received funding from Health∼Holland Topsector Life Sciences and Health and the Dutch Collaborating Health Funds (SGF).

Authors’ contribution

Conceptualization, DZ; writing-original draft preparation, DZ; literature search: all; writing- review and editing, all; visualization, DZ; supervision, DZ, RB, AK; project administration, DZ. All authors have read and approved the final manuscript.

Conflict of interest

DZ is affiliated with Microbiome Center. IB was employee at Winclove Probiotics at the time of writing. RJB has received consulting fees from Akkermansia Company, Belgium, and research grants from AnaBio Technologies, Ireland and Biogaia AB, Sweden. None of the other authors have any interests to declare.

Funding

This work is a result of the MyOwnResearch project (in full: MyOwnResearch: Homogeneous subgroup identification in fatigue management across chronic autoimmune syndromes through Single Subject Study design). The MyOwnResearch project received funding from Health∼Holland Topsector Life Sciences and Health and the Dutch Collaborating Health Funds (SGF)

References

  • Abdallah, M.S., Mosalam, E.M., Zidan, A.-A.A., Elattar, K.S., Zaki, S.A., Ramadan, A.N. and Ebeid, A.M., 2020. The antidiabetic metformin as an adjunct to antidepressants in patients with major depressive disorder: a proof-of-concept, randomized, double-blind, placebo-controlled trial. Neurotherapeutics 17: 1897-1906. https://doi.org/10.1007/s13311-020-00878-7

  • Abdallah, M.S., Mosalam, E.M., Zidan, A.-A.A., Elattar, K.S., Zaki, S.A., Ramadan, A.N. and Ebeid, A.M., 2022. Retraction note: the antidiabetic metformin as an adjunct to antidepressants in patients with major depressive disorder: a proof-of-concept, randomized, double-blind, placebo-controlled trial. Neurotherapeutics 19: 1687. https://doi.org/10.1007/s13311-022-01291-y

  • Altadill, T., Espadaler-Mazo, J. and Liong, M.-T., 2021. Effects of a lactobacilli probiotic on reducing duration of URTI and fever, and use of URTI-associated medicine: a re-analysis of a randomized, placebo-controlled study. Microorganisms 9: 528. https://doi.org/10.3390/microorganisms9030528

  • Ames Room (Philip Zimbardo), 2010. Available at: https://www.youtube.com/watch?v=hCV2Ba5wrcs.

  • Baumfeld Andre, E., Reynolds, R., Caubel, P., Azoulay, L. and Dreyer, N.A., 2020. Trial designs using real-world data: The changing landscape of the regulatory approval process. Pharmacoepidemiology and Drug Safety 29: 1201-1212. https://doi.org/10.1002/pds.4932

  • Berg, G., Rybakova, D., Fischer, D., Cernava, T., Vergès, M.-C.C., Charles, T., Chen, X., Cocolin, L., Eversole, K., Corral, G.H., Kazou, M., Kinkel, L., Lange, L., Lima, N., Loy, A., Macklin, J.A., Maguin, E., Mauchline, T., McClure, R., Mitter, B., Ryan, M., Sarand, I., Smidt, H., Schelkle, B., Roume, H., Kiran, G.S., Selvin, J., De Souza, R.S.C., Van Overbeek, L., Singh, B.K., Wagner, M., Walsh, A., Sessitsch, A. and Schloter, M., 2020. Microbiome definition re-visited: old concepts and new challenges. Microbiome 8: 103. https://doi.org/10.1186/s40168-020-00875-0

  • Blackstone, E.H., 2019. Precision medicine versus evidence-based medicine. Circulation 140: 1236-1238. https://doi.org/10.1161/CIRCULATIONAHA.119.043014

  • Blane, D., Burton-Jeangros, C., Cullati, S. and Sacker, A. (eds.), 2015. A life course perspective on health trajectories and transitions. Springer International Publishing, Cham, Switzerland. https://doi.org/10.1007/978-3-319-20484-0

  • Bourgonje, A.R., Von Martels, J.Z.H., De Vos, P., Faber, K.N. and Dijkstra, G., 2018. Increased fecal calprotectin levels in Crohn’s disease correlate with elevated serum Th1- and Th17-associated cytokines. PLoS ONE 13: e0193202. https://doi.org/10.1371/journal.pone.0193202

  • Briggs Early, K. and Stanley, K., 2018. Position of the Academy of Nutrition and Dietetics: the role of medical nutrition therapy and registered dietitian nutritionists in the prevention and treatment of prediabetes and type 2 diabetes. Journal of the Academy of Nutrition and Dietetics 118: 343-353. https://doi.org/10.1016/j.jand.2017.11.021

  • Burcu, M., Manzano-Salgado, C.B., Butler, A.M. and Christian, J.B., 2022. A framework for extension studies using real-world data to examine long-term safety and effectiveness. Therapeutic Innovation & Regulatory Science 56: 15-22. https://doi.org/10.1007/s43441-021-00322-8

  • Burns, P.B., Rohrich, R.J. and Chung, K.C., 2011. The levels of evidence and their role in evidence-based medicine. Plastic and Reconstructive Surgery 128: 305-310. https://doi.org/10.1097/PRS.0b013e318219c171

  • Bush, C.L., Blumberg, J.B., El-Sohemy, A., Minich, D.M., Ordovás, J.M., Reed, D.G. and Behm, V.A.Y., 2020. Toward the definition of personalized nutrition: a proposal by the american nutrition association. Journal of the American College of Nutrition 39: 5-15. https://doi.org/10.1080/07315724.2019.1685332

  • Casellas, F., Guise, C.H., Robles, V., Navarro, E. and Borruel, N., 2017. Patient preferences for inflammatory bowel disease treatment objectives. Digestive and Liver Disease 49: 152-156. https://doi.org/10.1016/j.dld.2016.09.009

  • Chakravartty, A., 2017. Scientific Realism. In: Zalta, E.N. (ed.) The Stanford Encyclopedia of Philosophy. Metaphysics Research Lab, Stanford University. Available at: https://plato.stanford.edu/archives/sum2017/entries/scientific-realism/.

  • Chan, K.L., Cathomas, F. and Russo, S.J., 2019. Central and peripheral inflammation link metabolic syndrome and major depressive disorder. Physiology 34: 123-133. https://doi.org/10.1152/physiol.00047.2018

  • Chong, H.-X., Yusoff, N.A.A., Hor, Y.-Y., Lew, L.-C., Jaafar, M.H., Choi, S.-B., Yusoff, M.S.B., Wahid, N., Abdullah, M.F.I.L., Zakaria, N., Ong, K.-L., Park, Y.-H. and Liong, M.-T., 2019a. Lactobacillus plantarum DR7 alleviates stress and anxiety in adults: a randomised, double-blind, placebo-controlled study. Beneficial Microbes 10: 355-373. https://doi.org/10.3920/BM2018.0135

  • Chong, H.-X., Yusoff, N.A.A., Hor, Y.-Y., Lew, L.-C., Jaafar, M.H., Choi, S.-B., Yusoff, M.S.B., Wahid, N., Abdullah, M.F.I.L., Zakaria, N., Ong, K.-L., Park, Y.-H. and Liong, M.-T., 2019b. Lactobacillus plantarum DR7 improved upper respiratory tract infections via enhancing immune and inflammatory parameters: A randomized, double-blind, placebo-controlled study. Journal of Dairy Science 102: 4783-4797. https://doi.org/10.3168/jds.2018-16103

  • Christovich, A. and Luo, X.M., 2022. Gut microbiota, leaky gut, and autoimmune diseases. Frontiers in Immunology 13: 946248. https://doi.org/10.3389/fimmu.2022.946248

  • Chuang, L.M., Jou, T.S., Yang, W.S., Wu, H.P., Huang, S.H., Tai, T.Y. and Lin, B.J., 1992. Therapeutic effect of guar gum in patients with non-insulin-dependent diabetes mellitus. Journal of the Formosan Medical Association = Taiwan Yi Zhi 91: 15-19.

  • Council conclusions on personalised medicine for patients, 2015. Available at: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv%3AOJ.C_.2015.421.01.0002.01.ENG&toc=OJ%3AC%3A2015%3A421%3AFULL.

  • Cunningham, M., Azcarate-Peril, M.A., Barnard, A., Benoit, V., Grimaldi, R., Guyonnet, D., Holscher, H.D., Hunter, K., Manurung, S., Obis, D., Petrova, M.I., Steinert, R.E., Swanson, K.S., van Sinderen, D., Vulevic, J. and Gibson, G.R., 2021. Shaping the future of probiotics and prebiotics. Trends in Microbiology 29: 667-685. https://doi.org/10.1016/j.tim.2021.01.003

  • Dall’Alba, V., Silva, F.M., Antonio, J.P., Steemburgo, T., Royer, C.P., Almeida, J.C., Gross, J.L. and Azevedo, M.J., 2013. Improvement of the metabolic syndrome profile by soluble fibre - guar gum - in patients with type 2 diabetes: a randomised clinical trial. British Journal of Nutrition 110: 1601-1610. https://doi.org/10.1017/S0007114513001025

  • Dekkers, O.M., von Elm, E., Algra, A., Romijn, J.A. and Vandenbroucke, J.P., 2010. How to assess the external validity of therapeutic trials: a conceptual approach. International Journal of Epidemiology 39: 89-94. https://doi.org/10.1093/ije/dyp174

  • Desjardins, E.M. and Steinberg, G.R., 2018. Emerging role of AMPK in brown and beige adipose tissue (BAT): implications for obesity, insulin resistance, and type 2 diabetes. Current Diabetes Reports 18: 80. https://doi.org/10.1007/s11892-018-1049-6

  • Durazzi, F., Sala, C., Castellani, G., Manfreda, G., Remondini, D. and De Cesare, A., 2021. Comparison between 16S rRNA and shotgun sequencing data for the taxonomic characterization of the gut microbiota. Scientific Reports 11: 3030. https://doi.org/10.1038/s41598-021-82726-y

  • Eichelberger, M., Hagen, H., Kedrowski, M., Kransz, N., Shah, S. and Taylor, N., 2021. Patients want to feel better. who should pay for that? BCG Global Available at: https://www.bcg.com/publications/2021/evaluating-coverage-quality-of-life-benefits.

  • Emmert-Streib, F., 2013. Personalized medicine: Has it started yet? A reconstruction of the early history. Frontiers in Genetics 3: 313. https://doi.org/10.3389/fgene.2012.00313

  • Ernst, E. and Pittler, M.H., 2006. Efficacy or effectiveness? Journal of Internal Medicine 260: 488-490. https://doi.org/10.1111/j.1365-2796.2006.01707.x

  • Fassarella, M., Blaak, E.E., Penders, J., Nauta, A., Smidt, H. and Zoetendal, E.G., 2020. Gut microbiome stability and resilience: elucidating the response to perturbations in order to modulate gut health. Gut 70: 595-605. https://doi.org/10.1136/gutjnl-2020-321747

  • Felder, M., van de Bovenkamp, H., Meerding, W.J. and de Bont, A., 2021. Who contextualises clinical epidemiological evidence? A political analysis of the problem of evidence-based medicine in the layered Dutch healthcare system. Health Policy 125: 34-40. https://doi.org/10.1016/j.healthpol.2020.09.006

  • Franzosa, E.A., Huang, K., Meadow, J.F., Gevers, D., Lemon, K.P., Bohannan, B.J.M. and Huttenhower, C., 2015. Identifying personal microbiomes using metagenomic codes. Proceedings of the National Academy of Sciences of the USA 112: E2930-E2938. https://doi.org/10.1073/pnas.1423854112

  • Galea, S., Riddle, M. and Kaplan, G.A., 2010. Causal thinking and complex system approaches in epidemiology. International Journal of Epidemiology 39: 97-106. https://doi.org/10.1093/ije/dyp296

  • Gauch, H.G., 2003. Scientific method in practice. Cambridge University Press, New York, NY, USA, 435 pp.

  • Glasser, S.P., Salas, M. and Delzell, E., 2007. Importance and challenges of studying marketed drugs: what is a phase IV study? Common clinical research designs, registries, and self-reporting systems. Journal of Clinical Pharmacology 47: 1074-1086. https://doi.org/10.1177/0091270007304776

  • Gomaa, E.Z., 2020. Human gut microbiota/microbiome in health and diseases: a review. Antonie van Leeuwenhoek 113: 2019-2040. https://doi.org/10.1007/s10482-020-01474-7

  • Green, L.W., 2008. Making research relevant: if it is an evidence-based practice, where’s the practice-based evidence? Family Practice 25: i20-i24. https://doi.org/10.1093/fampra/cmn055.

  • Greenhalgh, T., 2020. Will COVID-19 be evidence-based medicine’s nemesis? PLOS Medicine 17: e1003266. https://doi.org/10.1371/journal.pmed.1003266

  • Guerrini, C.J., Kempner, J., Rasmussen, L.M. and Wexler, A., 2022. Diverse, emergent, disruptive: perspectives on and developments in biomedical citizen science. Citizen Science – Theory and Practice 7: 36. https://doi.org/10.5334/cstp.598

  • Guyatt, G., 1992. Evidence-Based medicine: a new approach to teaching the practice of medicine. JAMA 268: 2420. https://doi.org/10.1001/jama.1992.03490170092032

  • Guyatt, G.H., Haynes, R.B., Jaeschke, R.Z., Cook, D.J., Green, L., Naylor, C.D., Wilson, M.C., Richardson, W.S. and Group for the E.-B.M.W., 2000. Users’ guides to the medical literature: XXV. Evidence-based medicine: principles for applying the users’ guides to patient care. JAMA 284: 1290-1296. https://doi.org/10.1001/jama.284.10.1290

  • Hamer, J.A., Testani, D., Mansur, R.B., Lee, Y., Subramaniapillai, M. and McIntyre, R.S., 2019. Brain insulin resistance: A treatment target for cognitive impairment and anhedonia in depression. Experimental Neurology 315: 1-8. https://doi.org/10.1016/j.expneurol.2019.01.016

  • Haynes, R.B., Devereaux, P.J. and Guyatt, G.H., 2002. Clinical expertise in the era of evidence-based medicine and patient choice. BMJ Evidence-Based Medicine 7: 36-38. https://doi.org/10.1136/ebm.7.2.36

  • Health Holland, 2018. Top Sector LSH and Health Funds support the project MyOwnResearch with 2,6 million. Health Holland. Available at: https://www.health-holland.com/news/2018/06/myownresearch-beter-gezond-project.

  • Heintz-Buschart, A. and Wilmes, P., 2018. Human gut microbiome: function matters. Trends in Microbiology 26: 563-574. https://doi.org/10.1016/j.tim.2017.11.002

  • Heinzel, S., Jureczek, J., Kainulainen, V., Nieminen, A.I., Suenkel, U., von Thaler, A.-K., Kaleta, C., Eschweiler, G.W., Brockmann, K., Aho, V.T.E., Auvinen, P., Maetzler, W., Berg, D. and Scheperjans, F., 2024. Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum markers and clinical outcomes in older individuals. Scientific Reports 14: 13513. https://doi.org/10.1038/s41598-024-63893-0

  • Heneghan, C. and Mahtani, K.R., 2019. Absolute effects of statins in the elderly. BMJ Evidence-Based Medicine 24: 200-202. https://doi.org/10.1136/bmjebm-2019-111189

  • Hernán, M.A. and Robins, J.M., 2022. Causal inference: what if. Chapman & Hall/CRC, Boca Raton, FL, USA. Available at: https://www.hsph.harvard.edu/miguel-hernan/causal-inference-book/.

  • Hernández Medina, R., Kutuzova, S., Nielsen, K.N., Johansen, J., Hansen, L.H., Nielsen, M. and Rasmussen, S., 2022. Machine learning and deep learning applications in microbiome research. ISME Communications 2: 98. https://doi.org/10.1038/s43705-022-00182-9

  • Higgins, J. and Green, S., 2011. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration. Available at: www.handbook.cochrane.org.

  • Hillegass, E., Lukaszewicz, K. and Puthoff, M., 2022. Role of physical therapists in the management of individuals at risk for or diagnosed with venous thromboembolism: evidence-based clinical practice guideline 2022. Physical Therapy 102: pzac057. https://doi.org/10.1093/ptj/pzac057

  • Hopewell, S., Loudon, K., Clarke, M.J., Oxman, A.D. and Dickersin, K., 2009. Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database of Systematic Reviews 2009: MR000006. https://doi.org/10.1002/14651858.MR000006.pub3

  • Hsueh, P.-Y.S., Dey, S., Das, S. and Wetter, T., 2017. Making sense of patient-generated health data for interpretable patient-centered care: the transition from ‘more’ to ‘better’. In: Gundlapalli, A.V., Jaulent, M.-C. and Zhao, D. (eds.) MEDINFO 2017: Precision Healthcare through Informatics. IOS Press, Amsterdam, the Netherlands, pp. 113-117. https://doi.org/10.3233/978-1-61499-830-3-113

  • Illingworth, V. (ed.), 1991. The Penguin dictionary of physics. Penguin Books, London, UK, 544 pp.

  • Jackson, S.A., Schoeni, J.L., Vegge, C., Pane, M., Stahl, B., Bradley, M., Goldman, V.S., Burguière, P., Atwater, J.B. and Sanders, M.E., 2019. Improving end-user trust in the quality of commercial probiotic products. Frontiers in Microbiology 10: 739. https://doi.org/10.3389/fmicb.2019.00739

  • Julious, S.A. and Mullee, M.A., 1994. Confounding and Simpson’s paradox. BMJ 309: 1480-1481. https://doi.org/10.1136/bmj.309.6967.1480

  • Jüni, P., Altman, D.G. and Egger, M., 2001. Assessing the quality of controlled clinical trials. BMJ 323: 42-46. https://doi.org/10.1136/bmj.323.7303.42

  • Kelley, J.M. and Kaptchuk, T.J., 2010. Group analysis versus individual response: The inferential limits of randomized controlled trials. Contemporary Clinical Trials 31: 423-428. https://doi.org/10.1016/j.cct.2010.07.003

  • Kelly, M.P., Heath, I., Howick, J. and Greenhalgh, T., 2015. The importance of values in evidence-based medicine. BMC Medical Ethics 16: 69. https://doi.org/10.1186/s12910-015-0063-3

  • Kennedy-Martin, T., Curtis, S., Faries, D., Robinson, S. and Johnston, J., 2015. A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results. Trials 16: 495. https://doi.org/10.1186/s13063-015-1023-4

  • Kent, D.M., Steyerberg, E. and van Klaveren, D., 2018. Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects. BMJ 363: k4245. https://doi.org/10.1136/bmj.k4245

  • Klonoff, D.C., 2019. The expanding role of real-world evidence trials in health care decision making. Journal of Diabetes Science and Technology 14: 174-179. https://doi.org/10.1177/1932296819832653

  • Kramer, L.A. and Greek, R., 2018. Human stakeholders and the use of animals in drug development. Business and Society Review 123: 3-58. https://doi.org/10.1111/basr.12134

  • Kravitz, R.L., Duan, N.H. and Braslow, J., 2004. Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages. Milbank Quarterly 82: 661-687.

  • Legg, C. and Hookway, C., 2021. Pragmatism. In: Zalta, E.N. (ed.) The Stanford Encyclopedia of Philosophy. Metaphysics Research Lab, Stanford University, CA, USA. Available at: https://plato.stanford.edu/archives/sum2021/entries/pragmatism/.

  • Lew, L.-C., Choi, S.-B., Khoo, B.-Y., Sreenivasan, S., Ong, K.-L. and Liong, M.-T., 2018. Lactobacillus plantarum DR7 reduces cholesterol via phosphorylation of AMPK that down-regulated the mRNA expression of HMG-CoA reductase. Korean Journal for Food Science of Animal Resources 38: 350-361. https://doi.org/10.5851/kosfa.2018.38.2.350

  • Lin, B. and Wu, S., 2022. Digital transformation in personalized medicine with artificial intelligence and the internet of medical things. OMICS 26: 77-81. https://doi.org/10.1089/omi.2021.0037

  • Livingston, E.H., Elliot, A., Hynan, L. and Cao, J., 2009. Effect size estimation: a necessary component of statistical analysis. Archives of Surgery 144: 706. https://doi.org/10.1001/archsurg.2009.150

  • Lundh, A., Lexchin, J., Mintzes, B., Schroll, J.B. and Bero, L., 2017. Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews 2: MR000033. https://doi.org/10.1002/14651858.MR000033.pub3

  • Lyra e Silva, N. de M., Lam, M.P., Soares, C.N., Munoz, D.P., Milev, R. and De Felice, F.G., 2019. Insulin resistance as a shared pathogenic mechanism between depression and type 2 diabetes. Frontiers in Psychiatry 10: 57. https://doi.org/10.3389/fpsyt.2019.00057

  • Mackey, A. and Bassendowski, S., 2017. The history of evidence-based practice in nursing education and practice. Journal of Professional Nursing 33: 51-55. https://doi.org/10.1016/j.profnurs.2016.05.009

  • Malla, M.A., Dubey, A., Kumar, A., Yadav, S., Hashem, A. and Abd Allah, E.F., 2019. Exploring the human microbiome: the potential future role of next-generation sequencing in disease diagnosis and treatment. Frontiers in Immunology 9: 2868. https://doi.org/10.3389/fimmu.2018.02868

  • Marley, J., 2000. Efficacy, effectiveness, efficiency. Australian Prescriber 23: 114-115. https://doi.org/10.18773/austprescr.2000.131

  • Mason-Suares, H., Sweetser, D.A., Lindeman, N.I. and Morton, C.C., 2016. Training the future leaders in personalized medicine. Journal of Personalized Medicine 6: 1. https://doi.org/10.3390/jpm6010001

  • McCoy, L.G., 2020. What makes medical knowledge: on the epistemological tensions between ‘evidence-based medicine’ and ‘personalized medicine’. University of Toronto Medical Journal 97: 27-31.

  • Miyauchi, E., Shimokawa, C., Steimle, A., Desai, M.S. and Ohno, H., 2023. The impact of the gut microbiome on extra-intestinal autoimmune diseases. Nature Reviews Immunology 23: 9-23. https://doi.org/10.1038/s41577-022-00727-y

  • Montori, V.M., Brito, J.P. and Murad, M.H., 2013. The optimal practice of evidence-based medicine: incorporating patient preferences in practice guidelines. JAMA 310: 2503-2504. https://doi.org/10.1001/jama.2013.281422

  • Niiniluoto, I., 1991. Realism, relativism, and constructivism. Synthese 89: 135-162.

  • Nurk, S., Koren, S., Rhie, A., Rautiainen, M., Bzikadze, A.V., Mikheenko, A., Vollger, M.R., Altemose, N., Uralsky, L., Gershman, A., Aganezov, S., Hoyt, S.J., Diekhans, M., Logsdon, G.A., Alonge, M., Antonarakis, S.E., Borchers, M., Bouffard, G.G., Brooks, S.Y., Caldas, G.V., Chen, N.-C., Cheng, H., Chin, C.-S., Chow, W., de Lima, L.G., Dishuck, P.C., Durbin, R., Dvorkina, T., Fiddes, I.T., Formenti, G., Fulton, R.S., Fungtammasan, A., Garrison, E., Grady, P.G.S., Graves-Lindsay, T.A., Hall, I.M., Hansen, N.F., Hartley, G.A., Haukness, M., Howe, K., Hunkapiller, M.W., Jain, C., Jain, M., Jarvis, E.D., Kerpedjiev, P., Kirsche, M., Kolmogorov, M., Korlach, J., Kremitzki, M., Li, H., Maduro, V.V., Marschall, T., McCartney, A.M., McDaniel, J., Miller, D.E., Mullikin, J.C., Myers, E.W., Olson, N.D., Paten, B., Peluso, P., Pevzner, P.A., Porubsky, D., Potapova, T., Rogaev, E.I., Rosenfeld, J.A., Salzberg, S.L., Schneider, V.A., Sedlazeck, F.J., Shafin, K., Shew, C.J., Shumate, A., Sims, Y., Smit, A.F.A., Soto, D.C., Sović, I., Storer, J.M., Streets, A., Sullivan, B.A., Thibaud-Nissen, F., Torrance, J., Wagner, J., Walenz, B.P., Wenger, A., Wood, J.M.D., Xiao, C., Yan, S.M., Young, A.C., Zarate, S., Surti, U., McCoy, R.C., Dennis, M.Y., Alexandrov, I.A., Gerton, J.L., O’Neill, R.J., Timp, W., Zook, J.M., Schatz, M.C., Eichler, E.E., Miga, K.H. and Phillippy, A.M., 2022. The complete sequence of a human genome. Science 376: 44-53. https://doi.org/10.1126/science.abj6987

  • Ogilvie, D., Adams, J., Bauman, A., Gregg, E.W., Panter, J., Siegel, K.R., Wareham, N.J. and White, M., 2020. Using natural experimental studies to guide public health action: turning the evidence-based medicine paradigm on its head. Journal of Epidemiology and Community Health 74: 203-208. https://doi.org/10.1136/jech-2019-213085

  • Ordovas, J.M., Ferguson, L.R., Tai, E.S. and Mathers, J.C., 2018. Personalised nutrition and health. BMJ 361: bmj.k2173. https://doi.org/10.1136/bmj.k2173

  • Pan, A., Lin, X., Hemler, E. and Hu, F.B., 2018. Diet and cardiovascular disease: advances and challenges in population-based studies. Cell Metabolism 27: 489-496. https://doi.org/10.1016/j.cmet.2018.02.017

  • Parisi, G., Bottona, E., Carrara, M., Cardin, F., Faedo, A., Goldin, D., Marino, M., Pantalena, M., Tafner, G., Verdianelli, G., Zilli, M. and Leandro, G., 2005. Treatment effects of partially hydrolyzed guar gum on symptoms and quality of life of patients with irritable bowel syndrome. a multicenter randomized open trial. Digestive Diseases and Sciences 50: 1107-1112. https://doi.org/10.1007/s10620-005-2713-7

  • Park, J.-E., Jeong, G.-H., Lee, I.-K., Yoon, Y.-R., Liu, K.-H., Gu, N. and Shin, K.-H., 2018. A pharmacometabolomic approach to predict response to metformin in early-phase type 2 diabetes mellitus patients. Molecules 23: 1579. https://doi.org/10.3390/molecules23071579

  • Peterson, D.B., Ellis, P.R., Baylis, J.M., Fielden, P., Ajodhia, J., Leeds, A.R. and Jepson, E.M., 1987. Low dose guar in a novel food product: improved metabolic control in non-insulin-dependent diabetes. Diabetic Medicine 4: 111-115. https://doi.org/10.1111/j.1464-5491.1987.tb00843.x

  • Plaza-Diaz, J., Ruiz-Ojeda, F.J., Gil-Campos, M. and Gil, A., 2019. Mechanisms of action of probiotics. Advances in Nutrition 10: S49-S66. https://doi.org/10.1093/advances/nmy063

  • Quigley, E.M.M., Murray, J.A. and Pimentel, M., 2020. AGA clinical practice update on small intestinal bacterial overgrowth: expert review. Gastroenterology 159: 1526-1532. https://doi.org/10.1053/j.gastro.2020.06.090

  • Revel-Muroz, A., Akulinin, M., Shilova, P., Tyakht, A. and Klimenko, N., 2023. Stability of human gut microbiome: Comparison of ecological modelling and observational approaches. Computational and Structural Biotechnology Journal 21: 4456-4468. https://doi.org/10.1016/j.csbj.2023.08.030

  • Romano, C., Comito, D., Famiani, A., Calamarà, S. and Loddo, I., 2013. Partially hydrolyzed guar gum in pediatric functional abdominal pain. World Journal of Gastroenterology 19: 235-240. https://doi.org/10.3748/wjg.v19.i2.235

  • Sackett, D.L., Rosenberg, W.M., Gray, J.A., Haynes, R.B. and Richardson, W.S., 1996. Evidence based medicine: what it is and what it isn’t. BMJ 312: 71-72. https://doi.org/10.1136/bmj.312.7023.71

  • Sanders, M.E., Merenstein, D.J., Reid, G., Gibson, G.R. and Rastall, R.A., 2019. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nature Reviews Gastroenterology and Hepatology 16: 605-616. https://doi.org/10.1038/s41575-019-0173-3

  • Schünemann, H.J., Brożek, J.L., Guyatt, G. and Oxman, A.D., 2013. GRADE Handbook. Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. Available at: https://gdt.gradepro.org/app/handbook/handbook.html.

  • Senn, S., 2018. Statistical pitfalls of personalized medicine. Nature 563: 619-621. https://doi.org/10.1038/d41586-018-07535-2

  • Siontis, K.C., Evangelou, E. and Ioannidis, J.P., 2011. Magnitude of effects in clinical trials published in high-impact general medical journals. International Journal of Epidemiology 40: 1280-1291. https://doi.org/10.1093/ije/dyr095

  • Sturmberg, J.P., Bennett, J.M., Martin, C.M. and Picard, M., 2017. ‘Multimorbidity’ as the manifestation of network disturbances. Journal of Evaluation in Clinical Practice 23: 199-208. https://doi.org/10.1111/jep.12587

  • Sturmberg, J.P. and Marcum, J.A., 2023. From cause and effect to causes and effects. Journal of Evaluation in Clinical Practice 30: 296-308. https://doi.org/10.1111/jep.13814

  • Subbiah, V., 2023. The next generation of evidence-based medicine. Nature Medicine 29: 49-58. https://doi.org/10.1038/s41591-022-02160-z

  • Szajewska, H., Horvath, A. and Kołodziej, M., 2015. Systematic review with meta-analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics 41: 1237-1245. https://doi.org/10.1111/apt.13214

  • Szajewska, H. and Kołodziej, M., 2015. Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Alimentary Pharmacology & Therapeutics 42: 793-801. https://doi.org/10.1111/apt.13344

  • Tait, G., 2005. The ADHD debate and the philosophy of truth. International Journal of Inclusive Education 9: 17-38. https://doi.org/10.1080/1360311042000299775

  • Tan, Y.Y., Papez, V., Chang, W.H., Mueller, S.H., Denaxas, S. and Lai, A.G., 2022. Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England. The Lancet Healthy Longevity 3: e674-e689. https://doi.org/10.1016/S2666-7568(22)00186-6

  • te Meerman, S., Batstra, L., Freedman, J.E., Hoekstra, R. and Grietens, H., 2020. ADHD and brain anatomy: what do academic textbooks used in the Netherlands tell students? Children & Society 34: 136-150. https://doi.org/10.1111/chso.12362

  • Thurber, S., Sheehan, W. and Roberts, R.J., 2009. Attention deficit hyperactivity disorder and scientific epistemology. Dialogues in Philosophy, Mental and Neuro Sciences 2: 33-39.

  • Tierney, B.T., Yang, Z., Luber, J.M., Beaudin, M., Wibowo, M.C., Baek, C., Mehlenbacher, E., Patel, C.J. and Kostic, A.D., 2019. The landscape of genetic content in the gut and oral human microbiome. Cell Host & Microbe 26: 283-295.e8. https://doi.org/10.1016/j.chom.2019.07.008

  • Tinetti, M.E., Fried, T.R. and Boyd, C.M., 2012. Designing health care for the most common chronic condition – multimorbidity. JAMA 307: 2493-2494. https://doi.org/10.1001/jama.2012.5265

  • Tonelli, M.R. and Shirts, B.H., 2017. Knowledge for precision medicine: mechanistic reasoning and methodological pluralism. JAMA 318: 1649-1650. https://doi.org/10.1001/jama.2017.11914

  • Torres, N. and Tovar, A.R., 2021. The present and future of personalized nutrition. Revista de Investigación Clı́nica 73: 321-325. https://doi.org/10.24875/RIC.21000346

  • Toulmin, S., 1990. Cosmopolis: the hidden agenda of modernity. Free Press, New York, NY, USA. 228 pp.

  • Van Baarlen, P., Troost, F.J., van Hemert, S., van der Meer, C., de Vos, W.M., de Groot, P.J., Hooiveld, G.J.E.J., Brummer, R.-J.M. and Kleerebezem, M., 2009. Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proceedings of the National Academy of Sciences of the USA 106: 2371-2376. https://doi.org/10.1073/pnas.0809919106

  • Van der Geest, A.M., Besseling-van der Vaart, I., Schellinger-de Goede, E.M., van der Waal, M.B., Claassen, E., Flach, J. and van de Burgwal, L.H.M., 2021. Multispecies probiotics promote perceived human health and wellbeing: insights into the value of retrospective studies on user experiences. Beneficial Microbes 12: 413-430. https://doi.org/10.3920/BM2020.0162

  • Vandeputte, D., De Commer, L., Tito, R.Y., Kathagen, G., Sabino, J., Vermeire, S., Faust, K. and Raes, J., 2021. Temporal variability in quantitative human gut microbiome profiles and implications for clinical research. Nature Communications 12: 6740. https://doi.org/10.1038/s41467-021-27098-7

  • World Health Organization (WHO), 2022. Non communicable diseases. Available at: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases.

  • Xiong, R., Aiken, E., Caldwell, R., Vernon, S.D., Kozhaya, L., Gunter, C., Bateman, L., Unutmaz, D. and Oh, J., 2025. AI-driven multi-omics modeling of myalgic encephalomyelitis/chronic fatigue syndrome. Nature Medicine 31: 2991-3001. https://doi.org/10.1038/s41591-025-03788-3

  • Yap, P.-G., Choi, S.-B. and Liong, M.-T., 2020. Allantoin, a potential metabolite that promotes AMPK phosphorylation and suppresses cholesterol biosynthesis via the mevalonate pathway and Bloch pathway. Applied Biochemistry and Biotechnology 191: 226-244. https://doi.org/10.1007/s12010-020-03265-2

  • Zeilstra, D., Younes, J.A., Brummer, R.J. and Kleerebezem, M., 2018. Perspective: fundamental limitations of the randomized controlled trial method in nutritional research: the example of probiotics. Advances in Nutrition 9: 561-571. https://doi.org/10.1093/advances/nmy046

  • Zhang, J. and Knight, R., 2023. Genomic mutations within the host microbiome: adaptive evolution or purifying selection. Engineering 20: 96-102. https://doi.org/10.1016/j.eng.2021.11.018

  • Zhang, X., Zhang, Y., Ye, X., Guo, X., Zhang, T. and He, J., 2016. Overview of phase IV clinical trials for postmarket drug safety surveillance: a status report from the ClinicalTrials.gov registry. BMJ Open 6: e010643. https://doi.org/10.1136/bmjopen-2015-010643


Plaats een reactie ...

Reageer op "Gezonde voeding is een kwestie van proberen, aldus stellen Dennis Zeilstra en collega's in een artikel dat op foodlog verder wordt beschreven"


Gerelateerde artikelen
 

Gerelateerde artikelen

Gezonde voeding is een kwestie >> Ouderen (60+) die zich zowel >> Leefstijlaanbeveling neurologie >> Leefstijl aanpassingen kan >> Leefstijl verandering, niet >> Leefstijl en voeding heeft >> Kanker is voor de helft te >> FODMAP-dieet stimulatie via >> Gezonde leefstijl zonder roken, >> Gezonde leefstijl met volkoren >>